SpringWorks Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of SWTX for the last quarter is 49.30 M USD, and it's 17.46% lower compared to the previous quarter. The net income of Q3 24 is -53.53 M USD.